These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 3140446)
41. On evasion of Trypanosoma cruzi from the host immune response. Lymphoproliferative responses to trypanosomal antigens during acute and chronic experimental Chagas' disease. Kierszenbaum F Immunology; 1981 Nov; 44(3):641-8. PubMed ID: 6797934 [TBL] [Abstract][Full Text] [Related]
42. Spontaneous lytic activity against allogeneic tumor cells and depression of specific cytotoxic responses in mice infected with Trypanosoma cruzi. Hatcher FM; Kuhn RE J Immunol; 1981 Jun; 126(6):2436-42. PubMed ID: 6785354 [TBL] [Abstract][Full Text] [Related]
43. Tissue tropism of different Trypanosoma cruzi strains. Melo RC; Brener Z J Parasitol; 1978 Jun; 64(3):475-82. PubMed ID: 96243 [TBL] [Abstract][Full Text] [Related]
44. Experimental Chagas disease. Innate immune response in Balb/c mice previously vaccinated with Trypanosoma rangeli. I. The macrophage shows immunological memory: Reality or fiction? Basso B; Marini V Immunobiology; 2014 Apr; 219(4):275-84. PubMed ID: 24321621 [TBL] [Abstract][Full Text] [Related]
46. Dogs infected with the blood trypomastigote form of Trypanosoma cruzi display an increase expression of cytokines and chemokines plus an intense cardiac parasitism during acute infection. de Souza SM; Vieira PM; Roatt BM; Reis LE; da Silva Fonseca K; Nogueira NC; Reis AB; Tafuri WL; Carneiro CM Mol Immunol; 2014 Mar; 58(1):92-7. PubMed ID: 24317279 [TBL] [Abstract][Full Text] [Related]
47. Inhibition of Trypanosoma cruzi-specific immune responses by a protein produced by T. cruzi in the course of Chagas' disease. Kierszenbaum F; Lopez HM; Sztein MB Immunology; 1994 Mar; 81(3):462-7. PubMed ID: 8206517 [TBL] [Abstract][Full Text] [Related]
48. The tissue specific tropism in Trypanosoma cruzi. Is it true? Añez N; Crisante G Acta Trop; 2021 Jan; 213():105736. PubMed ID: 33159898 [TBL] [Abstract][Full Text] [Related]
49. Essential role of VLA-4/VCAM-1 pathway in the establishment of CD8+ T-cell-mediated Trypanosoma cruzi-elicited meningoencephalitis. Roffê E; Silva AA; Marino AP; dos Santos PV; Lannes-Vieira J J Neuroimmunol; 2003 Sep; 142(1-2):17-30. PubMed ID: 14512161 [TBL] [Abstract][Full Text] [Related]
50. Molecular mimicry by Trypanosoma cruzi: the F1-160 epitope that mimics mammalian nerve can be mapped to a 12-amino acid peptide. Van Voorhis WC; Schlekewy L; Trong HL Proc Natl Acad Sci U S A; 1991 Jul; 88(14):5993-7. PubMed ID: 1712477 [TBL] [Abstract][Full Text] [Related]
51. Immunoblot analysis of trypomastigote excreted-secreted antigens as a tool for the characterization of Trypanosoma cruzi strains and isolates. Kesper N; de Almeida KA; Stolf AM; Umezawa ES J Parasitol; 2000 Aug; 86(4):862-7. PubMed ID: 10958475 [TBL] [Abstract][Full Text] [Related]
52. Use of clomipramine as chemotherapy of the chronic phase of Chagas disease. Fauro R; Lo Presti S; Bazan C; Baez A; Strauss M; Triquell F; Cremonezzi D; Negrete OS; Willhuber GC; Paglini-Oliva P; Rivarola HW Parasitology; 2013 Jun; 140(7):917-27. PubMed ID: 23534690 [TBL] [Abstract][Full Text] [Related]
55. Comparative pathogenicity in Swiss mice of Trypanosoma cruzi IV from northern Brazil and Trypanosoma cruzi II from southern Brazil. Meza SK; Kaneshima EN; Silva Sde O; Gabriel M; de Araújo SM; Gomes ML; Monteiro WM; Barbosa Md; Toledo MJ Exp Parasitol; 2014 Nov; 146():34-42. PubMed ID: 25296157 [TBL] [Abstract][Full Text] [Related]
56. A comparative pathological study of three strains of Trypanosoma cruzi in an experimental model. de Diego JA; Penin P; del Rey J; Mayer R; Gamallo C Histol Histopathol; 1991 Apr; 6(2):199-206. PubMed ID: 1802119 [TBL] [Abstract][Full Text] [Related]
57. Biological behavior of different Trypanosoma cruzi isolates circulating in an endemic area for Chagas disease in the Gran Chaco region of Argentina. Ragone PG; Pérez Brandán C; Padilla AM; Monje Rumi M; Lauthier JJ; Alberti D'Amato AM; Tomasini N; Cimino RO; Romero NM; Portelli M; Nasser JR; Basombrío MA; Diosque P Acta Trop; 2012 Sep; 123(3):196-201. PubMed ID: 22643298 [TBL] [Abstract][Full Text] [Related]
58. Use of Tc-rCRP as a target for lytic antibody titration after experimental Trypanosoma cruzi infection. Marques T; Silva GC; Henrique Paiva PM; Nascentes GAN; Ramirez LE; Norris K; Meira WSF Exp Parasitol; 2018 Jan; 184():103-108. PubMed ID: 29246832 [TBL] [Abstract][Full Text] [Related]
59. Elucidating the impact of low doses of nano-formulated benznidazole in acute experimental Chagas disease. Rial MS; Scalise ML; Arrúa EC; Esteva MI; Salomon CJ; Fichera LE PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006119. PubMed ID: 29267280 [TBL] [Abstract][Full Text] [Related]
60. Intracellular co-localization of Trypanosoma cruzi and inducible nitric oxide synthase (iNOS): evidence for dual pathway of iNOS induction. Rottenberg ME; Castaños-Velez E; de Mesquita R; Laguardia OG; Biberfeld P; Orn A Eur J Immunol; 1996 Dec; 26(12):3203-13. PubMed ID: 8977323 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]